FDA approves first treatment for rare form of skin cancer - FDA Press Releases

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer.

from Food and Drug Administration--Press Releases http://ift.tt/2nNhUuc
via IFTTT